Nanoparticle Geometry Boosts Antibiotic Power Against MRSA

Antimicrobial resistance is one of the most pressing threats in modern medicine, and researchers are increasingly turning to the physical properties of nanomaterials to find new ways to weaken drug-resistant bacteria. A team working with lyotropic liquid crystalline nanoparticles has now shown that a subtle geometric feature of these particles, their internal nanoscale curvature, can dramatically change how well a membrane-targeting antibiotic works against methicillin-resistant Staphylococcus aureus, better known as MRSA. The findings, published in Advanced Science, suggest that curvature itself, rather than drug loading or lipid composition, is a controllable design parameter for antibacterial nanomaterials.

The nanoparticles at the heart of the study are built from a simple mixture of phytantriol and a phospholipid called DPPS. By adjusting the salt concentration of the surrounding solution, the researchers could drive the same lipid formulation through a sequence of distinct internal structures. In pure water, the lipids assembled into lamellar vesicles, essentially flat bilayer spheres. Dilution into 0.1-times phosphate-buffered saline transformed them into so-called P-cubosomes, particles whose interiors form a bicontinuous cubic phase with the Im3m symmetry. A further step into full-strength PBS produced D-cubosomes with the Pn3m diamond-type cubic phase. Small-angle X-ray scattering and cryogenic electron microscopy confirmed each transition, and the particles kept their assigned structures even after being transferred into the biological assay medium used for all subsequent experiments.

What makes this platform powerful is that the three particle types are nearly identical in every measurable respect except curvature. Dynamic light scattering showed hydrodynamic diameters of roughly 125 to 142 nanometers, and all three displayed a near-neutral zeta potential of about minus 3 millivolts in the assay medium. Co-administration with the antibiotic daptomycin did not alter these colloidal properties. Yet when the researchers applied the Gauss-Bonnet theorem to the X-ray-derived lattice parameters, they calculated Gaussian curvatures of zero for the vesicles, about minus 0.07 per square nanometer for P-cubosomes, and minus 0.10 per square nanometer for D-cubosomes. The cubic particles expose saddle-shaped openings where internal water channels meet the particle surface, while the vesicle surface is topologically flat. Increasing salt screens electrostatic repulsion between lipid headgroups, reduces the interfacial area per molecule, and pushes the system toward progressively more negative curvature.

With this curvature hierarchy established, the team tested how the blank, drug-free particles interacted with six clinical MRSA strains. Confocal microscopy showed all three formulations gathering near the bacterial membrane, but quantitative assays revealed a clear trend. In the NPN uptake assay, which measures penetration into the hydrophobic membrane interior, D-cubosomes achieved the highest uptake factor of 9.5 at 64 micrograms per milliliter, closely followed by P-cubosomes at 9.4, while vesicles lagged at 8.1. D-cubosomes also triggered the strongest oxidative stress in bacterial cells. The particles alone, however, could not kill the bacteria; their role emerged only in combination with daptomycin, a lipopeptide antibiotic that disrupts Gram-positive membranes by binding to negatively charged lipids.

The combination experiments produced striking results. Adding subinhibitory daptomycin to vesicle suspensions reduced the minimum inhibitory concentration of the drug eight-fold compared with nanoparticle monotherapy. With P-cubosomes the reduction reached 32-fold, and with D-cubosomes it climbed to 64-fold. Similar trends held across all six MRSA strains tested. Notably, the fractional inhibitory concentration indices remained within the conventional indifferent range, meaning the effect is best described as curvature-dependent potentiation rather than formal pharmacodynamic synergy. Control experiments confirmed that ionic strength alone did not explain the enhancement, since daptomycin activity was unchanged in buffers of different salinity without nanoparticles.

Fluorescence live-dead staining quantified the bactericidal consequences. Daptomycin alone left approximately 81 percent of cells viable, comparable to untreated controls. Combined with vesicles, viability fell to about 15 percent; with P-cubosomes, to roughly 7 percent; and with D-cubosomes, to below 2 percent. Electron microscopy added visual weight to these numbers. Untreated MRSA cells showed smooth, uniform surfaces, and neither daptomycin alone nor any nanoparticle alone caused visible damage. The daptomycin-D-cubosome combination, however, produced extensive membrane disruption, with distinctive bread-crumb-like protrusions covering the cell surface, while the vesicle combination left morphology essentially intact and P-cubosomes caused only moderate blebbing. Transmission electron microscopy further showed D-cubosomes in the closest contact with bacterial envelopes, with visible cell lysis in the combination treatment.

To probe the mechanism at molecular resolution, the researchers turned to neutron reflectometry. They first confirmed with fluorescent peptidoglycan labeling that the nanoparticles were not primarily accumulating in the cell wall, justifying a simplified model membrane that recreates the S. aureus cytoplasmic membrane from phosphatidylglycerol, cardiolipin, and lysyl-phosphatidylglycerol in the same 69:12:19 molar ratio found in the bacterium. Using three isotopic contrasts, the team measured how each formulation remodeled this bilayer. Daptomycin with vesicles removed only 9.5 percent of the lipid volume fraction. The P-cubosome combination extracted 17.8 percent, consistent with partial lipid loss. The D-cubosome combination was by far the most destructive, stripping 36 percent of the lipid and allowing water to penetrate the bilayer, and a layer associated with D-cubosomes, roughly 33.5 angstroms thick, was detected deposited on the membrane surface.

The physical explanation draws on well-established membrane biophysics. According to Helfrich’s curvature-elastic energy model, membranes store elastic energy that depends on how far their shape deviates from a spontaneous curvature, and Gaussian curvature contributes directly to this energy landscape. Negative Gaussian curvature, the saddle-like geometry characteristic of the cubic phases, lowers the energetic barrier for membrane remodeling processes such as fusion and pore formation. The MRSA membrane, dominated by lysyl-phosphatidylglycerol, naturally favors positive curvature, so highly negatively curved nanoparticles create a curvature mismatch that generates localized stress, weakens lipid packing, and increases permeability. Daptomycin at subinhibitory levels presumably sensitizes the membrane, while the retained internal curvature of the nanoparticles governs how much remodeling follows.

Safety and in vivo data strengthened the case. Human embryonic kidney cells maintained at least 80 percent metabolic activity after 24 hours of exposure to any formulation alone or combined with daptomycin. In a mouse bacteremia model, intravenous infection with S. aureus followed by intraperitoneal treatment showed a clear curvature-dependent hierarchy of bacterial clearance. Free daptomycin at 10 milligrams per kilogram, chosen to represent a suboptimal therapeutic condition, did not significantly reduce organ bacterial burdens compared with saline. Blank nanoparticles alone produced a modest two log10 reduction. The daptomycin-vesicle combination roughly doubled that effect, the P-cubosome combination lowered counts to between 10,000 and 100,000 colony-forming units per gram, and the D-cubosome combination pushed bacterial counts in the kidney, liver, and spleen close to the detection limit of 100 CFU per gram, a five to six log10 improvement over the free drug.

The authors are careful to frame the animal work as a proof of concept rather than therapeutic validation. Serum proteins, lipoproteins, and endogenous lipases could remodel the nanoparticles before they reach infected tissues, and the study did not include pharmacokinetic analysis, long-term toxicity assessment, or survival endpoints. Future development will require plasma stability studies, quantitative measurement of any daptomycin association with the lipid phases, biodistribution data, dose optimization, and immunogenicity evaluation. Even so, the central message stands out clearly: by isolating curvature as the only structural variable in a matched nanoparticle platform, the study provides direct experimental evidence that nanoscale geometry, tunable through something as simple as salt concentration, can be programmed to amplify antibiotic activity against one of the world’s most dangerous drug-resistant pathogens.

Subject of Research: Curvature-modulated lyotropic liquid crystalline nanoparticles as antibacterial potentiators against MRSA

Article Title: Enhanced Antibacterial Properties of Lyotropic Liquid Crystalline Nanoparticles via Curvature Modulation

Article References: Lai, X., Wang, S., Ding, C., Kostoulias, X., Brun, A. P. L., Hsu, H.-Y., Jiang, J.-H., Wang, Y., Strugnell, R. A., Peleg, A. Y., & Shen, H.-H. (2026). Enhanced Antibacterial Properties of Lyotropic Liquid Crystalline Nanoparticles via Curvature Modulation. Advanced Science, 13(55), Article e76516. https://doi.org/10.1002/advs.76516

Image Credits: AI Generated

DOI: 10.1002/advs.76516

Keywords: antimicrobial resistance, MRSA, lyotropic liquid crystalline nanoparticles, cubosomes, Gaussian curvature, daptomycin, membrane disruption, neutron reflectometry, nanomedicine, Staphylococcus aureus, lipid nanoparticles, antibiotic potentiation